Organized around four case studies, the discussion will focus on current clinical evidence for optimal selection of immunotherapy and use of combination therapy. Topics covered include monitoring for and managing irAEs, care coordination and communication with non-oncology specialists, and assessment of institution- or practice-specific gaps in IO integration. Shared decision-making, reimbursement, and survivorship will also be discussed.
If you are an ACCC Cancer Program Member and are interested in hosting this live educational program at your site, please contact Janelle Schrag, Assistant Director of Research Programs, ACCC Provider Education.
This activity is supported by an educational grant from the Bristol-Myers Squibb Company.